Psilocybin-assisted group therapy for depression
Treatments studied
Part of Mental health clinical trials.
This trial tests whether a treatment called psilocybin (a hallucinogen that can help with depression) combined with group therapy can improve symptoms of depression. It requires participants to have significant depression symptoms and a support person to drive them home after each session.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 21 and 60 years old.
- You need to have current or past major depression (diagnosed by a professional).
- You need a trusted adult friend or relative to drive you home after treatment sessions.
- You must be willing to avoid alcohol and other psychoactive drugs within 24 hours of treatment sessions.
- If you are female and could become pregnant, you must use effective birth control and take pregnancy tests during the study.
- You cannot take certain antidepressants or other serotonin-affecting medicines, and you cannot have certain heart conditions or a history of seizures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
This study tests if psilocybin (a psychedelic) combined with cognitive behavioral therapy (CBT) can help people with major depression. You would receive the psilocybin in a supervised setting and have talk therapy before and after.
This trial tests whether a medicine called psilocybin (the active ingredient in 'magic mushrooms') combined with therapy can help treat depression. You would have a few sessions with a therapist and receive the medicine in a safe setting, which might improve your mood.
This trial tests whether taking very small, repeated doses of psilocybin (a substance found in magic mushrooms) along with talk therapy can help people with depression that hasn't gotten better with other treatments. You'll need to stop your current depression medications and avoid drugs or alcohol for the study period.
This trial tests whether a single dose of psilocybin can help people with treatment-resistant depression by changing how they focus on themselves. It aims to understand how psilocybin affects brain activity and self-related thinking.
This study tests whether a single dose of psilocybin (a psychedelic compound) can help treat depression by looking at brain changes on MRI. It is designed for people with moderate-to-severe depression who have not responded well to other treatments.
Hear when a new Depression - Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.